Literature DB >> 19325124

Invariant NKT cells inhibit development of the Th17 lineage.

Lennart T Mars1, Luiza Araujo, Philippe Kerschen, Séverine Diem, Elvire Bourgeois, Linh Pham Van, Nadège Carrié, Michel Dy, Roland S Liblau, André Herbelin.   

Abstract

T cells differentiate into functionally distinct effector subsets in response to pathogen encounter. Cells of the innate immune system direct this process; CD1d-restricted invariant natural killer T (iNKT) cells, for example, can either promote or inhibit Th(1) and Th(2) responses. Recently, a new subset of CD4(+) T helper cells, called Th(17), was identified that is implicated in mucosal immunity and autoimmune disorders. To investigate the influence of iNKT cells on the differentiation of naïve T cells we used an adoptive transfer model of traceable antigen-specific CD4(+) T cells. Transferred naïve CD25(-)CD62L(+) CD4(+) T cells were primed by antigen immunization of the recipient mice, permitting their expansion and Th(17) differentiation. This study establishes that in vivo activation of iNKT cells during T-cell priming impedes the commitment of naïve T cells to the Th(17) lineage. In vivo cytokine neutralization experiments revealed a role for IL-4, IL-10, and IFN-gamma in the iNKT-cell-mediated regulation of T-cell lineage development. Moreover, by comparing IL-17 production by antigen-experienced T cells from unmanipulated wild-type mice and iNKT-cell-deficient mice, we demonstrate an enhanced Th(17) response in mice lacking iNKT cells. This invigorated Th(17) response reverts to physiological levels when iNKT cells are introduced into Jalpha18(-/-) mice by adoptive transfer, indicating that iNKT cells control the Th(17) compartment at steady state. We conclude that iNKT cells play an important role in limiting development of the Th(17) lineage and suggest that iNKT cells provide a natural barrier against Th(17) responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325124      PMCID: PMC2669382          DOI: 10.1073/pnas.0809317106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  CD1-dependent dendritic cell instruction.

Authors:  Michael S Vincent; David S Leslie; Jenny E Gumperz; Xiaowei Xiong; Ethan P Grant; Michael B Brenner
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

2.  Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population.

Authors:  Jonathan M Coquet; Sumone Chakravarti; Konstantinos Kyparissoudis; Finlay W McNab; Lauren A Pitt; Brent S McKenzie; Stuart P Berzins; Mark J Smyth; Dale I Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

3.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

4.  Directional release of lymphokines from T cells.

Authors:  T R Mosmann
Journal:  Immunol Today       Date:  1988-10

Review 5.  Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.

Authors:  Lennart T Mars; Jan Novak; Roland S Liblau; Agnès Lehuen
Journal:  Trends Immunol       Date:  2004-09       Impact factor: 16.687

6.  Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.

Authors:  Matthew A Burchill; Dean T Nardelli; Douglas M England; David J DeCoster; John A Christopherson; Steven M Callister; Ronald F Schell
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.

Authors:  Roberto Furlan; Alessandra Bergami; Daniela Cantarella; Elena Brambilla; Masaro Taniguchi; Paolo Dellabona; Giulia Casorati; Gianvito Martino
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

8.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

9.  CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.

Authors:  Grazia Galli; Sandra Nuti; Simona Tavarini; Luisa Galli-Stampino; Claudia De Lalla; Giulia Casorati; Paolo Dellabona; Sergio Abrignani
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

10.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

Authors:  T Yoshimoto; W E Paul
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  29 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Authors:  Li Zhou; Kai Li; Yu-Ling Shi; Iltefat Hamzavi; Tian-Wen Gao; Marsha Henderson; Richard H Huggins; Oma Agbai; Bassel Mahmoud; Xiaofan Mi; Henry W Lim; Qing-Sheng Mi
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-12       Impact factor: 4.693

3.  Innate profiles of cytokines implicated on oral tolerance correlate with low- or high-suppression of humoral response.

Authors:  Maria F Silva; Alice O Kamphorst; Elize A Hayashi; Maria Bellio; Claudia R Carvalho; Ana M C Faria; Kátia C C Sabino; Marsen G P Coelho; Alberto Nobrega; Daniel Tavares; Antonio C Silva
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

4.  Diverse roles of natural killer T lymphocytes in liver and spleen in mice with experimental autoimmune uveitis.

Authors:  Shengya Zhao; Dadong Guo; Hongsheng Bi; Yan Cui; Xiaofeng Xie; Xingrong Wang; Jiao Li
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

5.  Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.

Authors:  Yong Chan Kim; Ai-Hong Zhang; Jeongheon Yoon; William E Culp; Jason R Lees; Kai W Wucherpfennig; David W Scott
Journal:  J Autoimmun       Date:  2018-05-30       Impact factor: 7.094

6.  IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset.

Authors:  Duygu Sag; Petra Krause; Catherine C Hedrick; Mitchell Kronenberg; Gerhard Wingender
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

Review 7.  Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Luc Van Kaer; Lan Wu; Vrajesh V Parekh
Journal:  Immunology       Date:  2015-06-22       Impact factor: 7.397

8.  Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.

Authors:  Vrajesh V Parekh; Lan Wu; Danyvid Olivares-Villagómez; Keith T Wilson; Luc Van Kaer
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

9.  iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions.

Authors:  Jinhong Wu; Jialong Yang; Kai Yang; Hongxia Wang; Balachandra Gorentla; Jinwook Shin; Yurong Qiu; Loretta G Que; W Michael Foster; Zhenwei Xia; Hongbo Chi; Xiao-Ping Zhong
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

10.  Regulation of IL-17 expression by the developmental pathway of CD4 T cells in the thymus.

Authors:  M Hanief Sofi; Zhiping Liu; Lingqiao Zhu; Qiao Yu; Mark H Kaplan; Cheong-Hee Chang
Journal:  Mol Immunol       Date:  2010-01-18       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.